SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody

Journal of Nuclear Medicine

Volumn 55, Issue 9, 2014, Pages 1519-1524

  Rijpkema, Mark ^a   Oyen, Wim J ^a   Bos, Desiree ^a   Franssen, Gerben M ^a   Goldenberg, David M ^b,c   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IMMUNOMEDICS INC   (United States)

^c CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

CEA; Colorectal cancer; Fluorescence imaging; Image guided surgery; MN 14

Indexed keywords

INDOCYANINE GREEN; LABETUZUMAB; LABETUZUMAB IRDYE 800CW DIETHYLENETRIAMINEPENTAACETIC ACID IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CARCINOEMBRYONIC ANTIGEN; DIAGNOSTIC AGENT; INDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG HALF LIFE; FEASIBILITY STUDY; FEMALE; FLUORESCENCE IMAGING; GUIDED IMAGERY; IMAGE ANALYSIS; IMAGE GUIDED SURGERY; IMAGING SYSTEM; ISOTOPE LABELING; MOUSE; NONHUMAN; PROTEIN TARGETING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECTROPHOTOMETRY; ULTRAFILTRATION; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; COMPUTER ASSISTED SURGERY; IMAGE-GUIDED SURGERY; IMMUNOLOGY; METHODOLOGY; MN-14; SPECTROFLUOROMETRY; TISSUE DISTRIBUTION;

CEA; COLORECTAL CANCER; FLUORESCENCE IMAGING; IMAGE-GUIDED SURGERY; MN-14;

ANIMALS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; INDIUM RADIOISOTOPES; MICE; MICE, INBRED BALB C; SPECTROMETRY, FLUORESCENCE; SURGERY, COMPUTER-ASSISTED; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84907014885     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.142141     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100:E1-E33.
3. Sjövall A, Granath F, Cedermark B, Glimelius B, Holm T. Loco-regional recurrence from colon cancer: a population-based study. Ann Surg Oncol. 2007; 14:432-440.
4. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312.
5. Povoski SP, Neff RL, Mojzisik CM, et al. A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol. 2009;7:11.
6. Luker GD, Luker KE. Optical imaging: current applications and future directions. J Nucl Med. 2008;49:1-4.
7. Keereweer S, Kerrebijn JD, van Driel PB, et al. Optical image-guided surgery: where do we stand? Mol Imaging Biol. 2011;13:199-207.
8. Sharkey RM, Goldenberg DM, Murthy S, et al. Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14. Cancer. 1993;71:2082-2096.
9. Hammarström S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol. 1999;9:67-81.
10. Behr TM, Salib AL, Liersch T, et al. Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study. Clin Cancer Res. 1999;5:3232s-3242s.
11. Behr TM, Sharkey RM, Sgouros G, et al. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry. Cancer. 1997;80:2591-2610.
12. Hajjar G, Sharkey RM, Burton J, et al. Phase I radioimmunotherapy trial with iodine-131-labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer. Clin Colorectal Cancer. 2002;2:31-42.
13. Koppe MJ, Bleichrodt RP, Soede AC, et al. Biodistribution and therapeutic efficacy of 125/131I-, 186Re-, 88/90Y-, or 177Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin. J Nucl Med. 2004;45:1224-1232.
14. Koppe MJ, Oyen WJ, Bleichrodt RP, et al. Combination therapy using the cyclooxygenase- 2 inhibitor Parecoxib and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. Cancer Immunol Immunother. 2006;55:47-55.
15. Koppe MJ, Oyen WJ, Bleichrodt RP, Verhofstad AA, Goldenberg DM, Boerman OC. Combination therapy using gemcitabine and radioimmunotherapy in nude mice with small peritoneal metastases of colonic origin. Cancer Biother Radiopharm. 2006;21:506-514.
16. Koppe MJ, Soede AC, Pels W, et al. Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin. Int J Cancer. 2003;106:965-972.
17. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol. 2009;7:5.
18. Hansen HJ, Goldenberg DM, Newman ES, Grebenau R, Sharkey RM. Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer. 1993;71:3478-3485.
19. Fraker PJ, Speck JC Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. 1978. Biochem Biophys Res Commun. 2012;425:510-518.
20. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods. 1984;72:77-89.
21. Cohen R, Stammes MA, de Roos IH, Stigter-van Walsum M, Visser GW, van Dongen GA. Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets. EJNMMI Res. 2011;1:31.
22. Valko K, Nunhuck S, Bevan C, Abraham MH, Reynolds DP. Fast gradient HPLC method to determine compounds binding to human serum albumin: relationships with octanol/water and immobilized artificial membrane lipophilicity. J Pharm Sci. 2003;92:2236-2248.
23. Blumenthal RD, Sharkey RM, Haywood L, et al. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies. Cancer Res. 1992;52:6036-6044.
24. Kaushal S, McElroy MK, Luiken GA, et al. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. J Gastrointest Surg. 2008;12:1938-1950.
25. Tran Cao HS, Kaushal S, Metildi CA, et al. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology. 2012;59:1994-1999.
26. Metildi CA, Kaushal S, Luiken GA, Talamini MA, Hoffman RM, Bouvet M. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J Surg Oncol. 2014;109:451-458.
27. Behr TM, Becker WS, Klein MW, Bair HJ, Scheele JR, Wolf FG. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTclabeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison. Cancer Res. 1995;55:5786s-5793s.
28. Juweid ME, Hajjar G, Swayne LC, et al. Phase I/II trial of 131I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma. Cancer. 1999;85:1828-1842.
29. Fuster D, Maurel J, Muxi A, et al. Is there a role for 99mTc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma? Q J Nucl Med. 2003;47:109-115.
30. Yao YF, Yang Z, Li ZF, Gu J. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58. World J Gastroenterol. 2007;13:1841-1846.
31. Takeda A, Shimada H, Okazumi S, et al. Preclinical assessment and pilot study using anti-CEA monoclonal antibody 1B2 for colorectal carcinoma imaging. Hepatogastroenterology. 2008;55:2054-2058.
32. Artiko V, Petrovic M, Sobic-Saranovic D, et al. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies. Hepatogastroenterology. 2011;58:347-351.
33. Juweid M, Sharkey RM, Swayne LC, Griffiths GL, Dunn R, Goldenberg DM. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoembryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. J Nucl Med. 1998;39:34-42.
34. Juweid M, Sharkey RM, Behr T, et al. Radioimmunotherapy of medullary thyroid cancer with iodine-131-labeled anti-CEA antibodies. J Nucl Med. 1996; 37:905-911.
35. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med. 2011;52:1778-1785.
36. Zhang Y, Hong H, Severin GW, et al. ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. Am J Transl Res. 2012;4:333-346.
37. Hong H, Zhang Y, Severin GW, et al. Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. Mol Pharm. 2012;9:2339-2349.
38. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212-222.
39. van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first inhuman results. Nat Med. 2011;17:1315-1319.